FTC Staffing Up For More Biopharma Merger Oversight
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency's 2011 budget request seeks to expand staff to monitor "increasingly complex" mergers and an "active merger enforcement agenda" in pharma and other key markets.